| Drug Name: | Dextromoramide (357-56-2) |
|---|---|
| PubChem ID: | 92943 |
| SMILES: | C[C@H](CN1CCOCC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N4CCCC4 |
| InchiKey: | INUNXTSAACVKJS-OAQYLSRUSA-N |
| Therapeutic Category: | Analgesics, Central Nervous System Agents, Central Nervous System Depressants, Narcotics, Peripheral Nervous System Agents, Sensory System Agents |
| Molecular Weight (dalton) | : | 392.543 |
| LogP | : | 3.5634 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 32.78 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Troleandomycin ((2751-09-9)) | Coma | Antagonistic | Uncertain but troleandomycin reduced the metabolism of the dextromoramide, thereby increasing its serum levels and effects may be the possible mechanism | Movement Disorders : A Brief Guide in Medication Management |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Brain Diseases | MetaADEDB |
| Catalepsy | MetaADEDB |
| Neural Tube Defects | MetaADEDB |